Drugmaker Shire agreed to acquire Baxalta International Inc after a six-month pursuit with $32bn cash and stock offer that will make it one of the world’s leading rare disease specialists.
Tag "rare disease"
Advertisements
Manufacturing & Supply Chain
Breaking News
- €24 million invested in start-ups in 2023 by Enterprise Ireland Enterprise Ireland, the government agency responsible for the development and growth of Irish companies in global markets, invested €24 million in Irish start-ups and supported a total of 156 start-up...
- New £20 million energy support fund for businesses launched in Northern Ireland A new £20 million fund which will offer support to local businesses in Northern Ireland to purchase and install energy efficient equipment that will help to reduce energy consumption and...
- Nucleic acid medicines manufacture receives £4.5 million in funding Five projects will receive funding to develop and commercialise innovative solutions for the manufacturing of nucleic acid medicines. Innovate UK has announced the winners of a funding competition to create...
- €2.4 billion investment in Kildare Innovation Campus Kildare Innovation Campus (KIC), located in a parkland setting on 184 acres between Celbridge and Leixlip, has announced a €2.4 billion investment in the further development of the site. This...
- IMR prepares to Demystify, Derisk and Deliver at the National Manufacturing & Supply Chain Conference & Exhibition Irish Manufacturing Research (IMR) will be participating in this year’s National Manufacturing & Supply Chain Conference & Exhibition, taking place on the 28th and 29th of May 2024, at the RDS...
© 2020 Copyright Premier Publishing. All Rights reserved.
Designed by PREMIER PUBLISHING
Designed by PREMIER PUBLISHING
Designed by 
